In this study, a DNA-based LFA was developed and a monogenic autosomal dominant disease, familial hypercholesterolemia (FH), with the E101K variant in the low-density lipoprotein receptor (LDLR) gene, was chosen to be the model for LFA detection. Here, LDLR is linked to familial hyperaldosteronism.